कृपया अन्य खोज का प्रयास करें
JW (Cayman) Therapeutics Co. Ltd, a clinical stage cell therapy company, engages in the research and development, manufacturing, and marketing of anti-tumor drugs in the People’s Republic of China. It offers cell-based immunotherapies, including CAR-T treatments, which is a treatment method that uses human immune cells to fight cancer. Its lead product candidate is Carteyva (relmacabtagene autoleucel), an anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy for the treatment of a range of hematological cancers. The company’s pipeline products include JWCAR129, an autologous CAR-T therapy for the treatment of multiple myeloma; JWATM204, a TCR T-cell therapy candidate for the treatment of HCC; and JWATM203, an autologous T-cell receptor mimic T-cell therapy targeting alpha-fetoprotein for the treatment of hepatocellular carcinoma. JW (Cayman) Therapeutics Co. Ltd was founded in 2016 and is headquartered in Shanghai, China.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Yiping Li | 59 | 2016 | Co-founder, Executive Chairman of the Board & CEO |
Cheng Liu | 56 | 2020 | Non-Executive Director |
Kin-Cheong Ho | 55 | 2020 | Independent Non-Executive Director |
Debra Yu | 58 | 2023 | Independent Non-Executive Director |
SungWon Song | 42 | 2023 | Non-Executive Director |
Ann Li Lee | 62 | 2020 | Independent Non-Executive Director |
Yiu Leung Cheung | 64 | 2020 | Independent Non-Executive Director |
Krishnan Viswanadhan | 45 | 2019 | Independent Non-Executive Director |
Xing Gao | 39 | 2020 | Non-Executive Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है